Structural and regulatory diversity shape HLA-C protein expression levels

Nature Communications

Volumn 8, Issue , 2017, Pages

  Kaur, Gurman ^a   Gras, Stephanie ^b,c   Mobbs, Jesse I ^b   Vivian, Julian P ^b,c   Cortes, Adrian ^d,e   Barber, Thomas ^d   Kuttikkatte, Subita Balaram ^a   Jensen, Lise Torp ^f   Attfield, Kathrine E ^a   Dendrou, Calliope A ^d,e   Carrington, Mary ^g,h   Mcvean, Gil ^e,i   Purcell, Anthony W ^b   Rossjohn, Jamie ^b,c,j   Fugger, Lars ^a,d,f  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b MONASH UNIVERSITY   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f AARHUS UNIVERSITY HOSPITAL   (Denmark)

^g FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^h MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

ⁱ UNIVERSITY OF OXFORD   (United Kingdom)

^j CARDIFF UNIVERSITY   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE PROTEIN; HLA ANTIBODY; HLA ANTIGEN CLASS 1; HLA C ANTIGEN; LUCIFERASE; MESSENGER RNA; RNA; PEPTIDE; PROTEIN BINDING;

ALLELE; DISEASE INCIDENCE; GENE EXPRESSION; IMMUNE RESPONSE; PEPTIDE; PHYLOGENETICS; PROTEIN; RNA;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANTIGEN BINDING; ARTICLE; BALANCING SELECTION; BIODIVERSITY; CELL SURFACE; CONTROLLED STUDY; EXON; GENE FREQUENCY; MOLECULAR PHYLOGENY; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REGULATORY MECHANISM; STRUCTURE ANALYSIS; ALLELE; ANIMAL; CHEMISTRY; CLASSIFICATION; GENE EXPRESSION REGULATION; GENETIC VARIATION; GENETICS; HUMAN; MAMMAL; METABOLISM; PAN TROGLODYTES; PHYLOGENY; PROMOTER REGION;

ALLELES; ANIMALS; EXONS; GENE EXPRESSION REGULATION; GENETIC VARIATION; HLA-C ANTIGENS; HUMANS; MAMMALS; PAN TROGLODYTES; PEPTIDES; PHYLOGENY; PROMOTER REGIONS, GENETIC; PROTEIN BINDING;

EID: 85021421984     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms15924     Document Type: Article

References (63)

1. Welter, D., et al. The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic Acids Res. 42, D1001-D1006 (2014).
2. Parham, P. MHC class I molecules and KIRs in human history, health and survival. Nat. Rev. Immunol. 5, 201-214 (2005).
3. Shiina, T., Hosomichi, K., Inoko, H., Kulski, J. K. The HLA genomic loci map: Expression, interaction, diversity and disease. J. Hum. Genet. 54, 15-39 (2009).
4. Apps, R., et al. Influence of HLA-C expression level on HIV control. Science 340, 87-91 (2013).
5. Petersdorf, E. W., et al. HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation. Blood 124, 3996-4003 (2014).
6. Koeffler, H. P., Ranyard, J., Yelton, L., Billing, R., Bohman, R. Gammainterferon induces expression of the HLA-D antigens on normal and leukemic human myeloid cells. Proc. Natl Acad. Sci. USA 81, 4080-4084 (1984).
7. Bashirova, A. A., Martin, M. P., McVicar, D. W., Carrington, M. The killer immunoglobulin-like receptor gene cluster: Tuning the genome for defense. Annu. Rev. Genomics Hum. Genet. 7, 277-300 (2006).
8. Snary, D., Barnstable, C. J., Bodmer, W. F., Crumpton, M. J. Molecular structure of human histocompatibility antigens: The HLA-C series. Eur. J. Immunol. 7, 580-585 (1977).
9. Zemmour, J., Parham, P. Distinctive polymorphism at the HLA-C locus: Implications for the expression of HLA-C. J. Exp. Med. 176, 937-950 (1992).
10. Apps, R., et al. Relative expression levels of the HLA class-I proteins in normal and HIV-infected cells. J. Immunol. 194, 3594-3600 (2015).
11. Kulkarni, S., et al. Genetic interplay between HLA-C and MIR148A in HIV control and Crohn disease. Proc. Natl Acad. Sci. USA 110, 20705-20710 (2013).
12. Fellay, J., et al. A whole-genome association study of major determinants for host control of HIV-1. Science 317, 944-947 (2007).
13. Kulkarni, S., et al. Differential microRNA regulation of HLA-C expression and its association with HIV control. Nature 472, 495-498 (2011).
14. Thomas, R., et al. HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C. Nat. Genet. 41, 1290-1294 (2009).
15. Apps, R., et al. HIV-1 Vpu mediates HLA-C downregulation. Cell Host Microbe 19, 686-695 (2016).
16. O'Huigin, C., et al. The molecular origin and consequences of escape from miRNA regulation by HLA-C alleles. Am. J. Hum. Genet. 89, 424-431 (2011).
17. Pereyra, F., et al. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 330, 1551-1557 (2010).
18. Gonzalez-Galarza, F. F., et al. Allele frequency net 2015 update: New features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations. Nucleic Acids Res. 43, D784-D788 (2015).
19. Borenstein, S. H., Graham, J., Zhang, X. L., Chamberlain, J. W. CD8\+ T cells are necessary for recognition of allelic, but not locus-mismatched or xeno-, HLA class I transplantation antigens. J. Immunol. 165, 2341-2353 (2000).
20. Hundhausen, C., et al. Allele-specific cytokine responses at the HLA-C locus: Implications for psoriasis. J. Invest. Dermatol. 132, 635-641 (2012).
21. Apps, R., et al. Human leucocyte antigen (HLA) expression of primary trophoblast cells and placental cell lines, determined using single antigen beads to characterize allotype specificities of anti-HLA antibodies. Immunology 127, 26-39 (2009).
22. Hilton, H. G., Parham, P. Direct binding to antigen-coated beads refines the specificity and cross-reactivity of four monoclonal antibodies that recognize polymorphic epitopes of HLA class I molecules. Tissue Antigens 81, 212-220 (2013).
23. Kim, E., Kwak, H., Ahn, K. Cytosolic aminopeptidases influence MHC class I-mediated antigen presentation in an allele-dependent manner. J. Immunol. 183, 7379-7387 (2009).
24. Neisig, A., Melief, C. J., Neefjes, J. Reduced cell surface expression of HLA-C molecules correlates with restricted peptide binding and stable TAP interaction. J. Immunol. 160, 171-179 (1998).
25. Sibilio, L., et al. A single bottleneck in HLA-C assembly. J. Biol. Chem. 283, 1267-1274 (2008).
26. Addo, M. M., et al. The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals. Proc. Natl Acad. Sci. USA 98, 1781-1786 (2001).
27. Vales-Gomez, M., Reyburn, H. T., Mandelboim, M., Strominger, J. L. Kinetics of interaction of HLA-C ligands with natural killer cell inhibitory receptors. Immunity 9, 337-344 (1998).
28. Rasmussen, M., et al. Uncovering the peptide-binding specificities of HLA-C: A general strategy to determine the specificity of any MHC class I molecule. J. Immunol. 193, 4790-4802 (2014).
29. Hofmann, S., et al. Rapid and sensitive identification of major histocompatibility complex class I-associated tumor peptides by Nano-LC MALDI MS/MS. Mol. Cell Proteomics 4, 1888-1897 (2005).
30. Falk, K., et al. Allele-specific peptide ligand motifs of HLA-C molecules. Proc. Natl Acad. Sci. USA 90, 12005-12009 (1993).
31. Miyadera, H., et al. density profiling reveals instability of autoimmunityassociated HLA. J. Clin. Invest. 125, 275-291 (2015).
32. Reits, E. A., et al. Radiation modulates the peptide repertoire, enhances MHC class I expression, induces successful antitumor immunotherapy. J. Exp. Med. 203, 1259-1271 (2006).
33. Faroudi, M., et al. Lytic versus stimulatory synapse in cytotoxic T lymphocyte/target cell interaction: Manifestation of a dual activation threshold. Proc. Natl Acad. Sci. USA 100, 14145-14150 (2003).
34. Thomas, R., et al. A novel variant marking HLA-DP expression levels predicts recovery from hepatitis B virus infection. J. Virol. 86, 6979-6985 (2012).
35. Cassidy, S. A., Cheent, K. S., Khakoo, S. I. Effects of peptide on NK cellmediated MHC I recognition. Front. Immunol. 5, 133 (2014).
36. Blais, M. E., Dong, T., Rowland-Jones, S. HLA-C as a mediator of natural killer and T-cell activation: Spectator or key player Immunology 133, 1-7 (2011).
37. Chappell, P., et al. Expression levels of MHC class I molecules are inversely correlated with promiscuity of peptide binding. Elife 4, e05345 2015.
38. Koch, M., et al. Structures of an MHC class I molecule from B21 chickens illustrate promiscuous peptide binding. Immunity 27, 885-899 (2007).
39. Zhang, J., et al. Narrow groove and restricted anchors of MHC class I molecule BF2∗0401 plus peptide transporter restriction can explain disease susceptibility of B4 chickens. J. Immunol. 189, 4478-4487 (2012).
40. Tregaskes, C. A., et al. Surface expression, peptide repertoire, thermostability of chicken class I molecules correlate with peptide transporter specificity. Proc. Natl Acad. Sci. USA 113, 692-697 (2016).
41. Obst, R., Armandola, E. A., Nijenhuis, M., Momburg, F., Hammerling, G. J. TAP polymorphism does not influence transport of peptide variants in mice and humans. Eur. J. Immunol. 25, 2170-2176 (1995).
42. Auton, A., et al. A fine-scale chimpanzee genetic map from population sequencing. Science 336, 193-198 (2012).
43. Gras, S., et al. The shaping of T cell receptor recognition by self-tolerance. Immunity 30, 193-203 (2009).
44. Cowieson, N. P., et al. MX1: A bending-magnet crystallography beamline serving both chemical and macromolecular crystallography communities at the Australian Synchrotron. J. Synchrotron Radiat. 22, 187-190 (2015).
45. Kabsch, W. Xds. Acta Crystallogr. D Biol. Crystallogr. 66, 125-132 (2010).
46. Evans, P. Scaling and assessment of data quality. Acta Crystallogr. D Biol. Crystallogr. 62, 72-82 (2006).
47. Collaborative Computational Project N. The CCP4 suite: Programs for protein crystallography. Acta Crystallogr. D Biol. Crystallogr. 50, 760-763 (1994).
48. Read, R. J. Pushing the boundaries of molecular replacement with maximum likelihood. Acta Crystallogr. D Biol. Crystallogr. 57, 1373-1382 (2001).
49. Choo, J. A., Liu, J., Toh, X., Grotenbreg, G. M., Ren, E. C. The immunodominant influenza A virus M158-66 cytotoxic T lymphocyte epitope exhibits degenerate class I major histocompatibility complex restriction in humans. J. Virol. 88, 10613-10623 (2014).
50. Emsley, P., Lohkamp, B., Scott, W. G., Cowtan, K. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486-501 (2010).
51. Vonrhein, C., et al. Data processing and analysis with the autoPROC toolbox. Acta Crystallogr. D Biol. Crystallogr. 67, 293-302 (2011).
52. DeLano, W. L. The PyMOL Molecular Graphics System. http://wwwpymolorg/(2002).
53. Schittenhelm, R. B., Dudek, N. L., Croft, N. P., Ramarathinam, S. H., Purcell, A. W. A comprehensive analysis of constitutive naturally processed and presented HLA-C∗04:01 (Cw4)-specific peptides. Tissue Antigens 83, 174-179 (2014).
54. Dudek, N. L., Croft, N. P., Schittenhelm, R. B., Ramarathinam, S. H., Purcell, A. W. A systems approach to understand antigen presentation and the immune response. Methods Mol. Biol. 1394, 189-209 (2016).
55. Robinson, J., et al. The IPD and IMGT/HLA database: Allele variant databases. Nucleic Acids Res. 43, D423-D431 (2015).
56. Edgar, R. C. MUSCLE: Multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 32, 1792-1797 (2004).
57. Ronquist, F., et al. MrBayes 3.2: Efficient Bayesian phylogenetic inference and model choice across a large model space. Syst. Biol. 61, 539-542 (2012).
58. Camacho, C., et al. BLAST\+: Architecture and applications. BMC Bioinform. 10, 421 (2009).
59. Rice, P., Longden, I., Bleasby, A. EMBOSS: The European Molecular Biology Open Software Suite. Trends Genet. 16, 276-277 (2000).
60. Paradis, E., Claude, J., Strimmer, K. APE: Analyses of Phylogenetics and Evolution in R language. Bioinformatics 20, 289-290 (2004).
61. Berman, H. M., et al. The protein data bank. Nucleic Acids Res. 28, 235-242 (2000).
62. Vizcaino, J. A., et al. 2016 update of the PRIDE database and its related tools. Nucleic Acids Res. 44, D447-D456 (2016).
63. Dundas, J., et al. CASTp: Computed atlas of surface topography of proteins with structural and topographical mapping of functionally annotated residues. Nucleic Acids Res. 34, W116-W118 (2006).